Trial intelligence / Profile preview

Comparison of metformin versus insulin regimens on postpartum glucose tolerance test results in women with gestational diabetes

IRCT20180103038196N5Phase 3Completed

Sponsor
Golestan University of Medical Sciences
Start
May 2018
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of metformin and human insulin in gestational diabetes mellitus (GDM) (2 arms), sponsored by Golestan University of Medical Sciences. Primary endpoint: Postpartum oral glucose tolerance test result. Started May 2018; status: completed.

02

Drugs

metforminhuman insulin
03

Conditions

gestational diabetes mellitus (GDM)

Beyond the preview

Go deeper on IRCT20180103038196N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180103038196N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call